查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402015

聚合酶炼式反应市场预测至 2030 年：按产品、应用、最终用户和地区进行的全球分析

Polymerase Chain Reaction Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球聚合酶炼式反应市场规模为 89 亿美元，预计在预测期内将以 11.5% 的复合年增长率增长，到 2030 年达到 191 亿美元。

聚合酶炼式反应是一种分子技术，透过体外扩增产生数百万个特定 DNA 链的拷贝。 PCR 灵敏度很高，可以检测微量 DNA。这在目标 DNA 浓度较低的应用中尤其有利，例如在某些疾病的早期阶段或在分析法医学样本中的微量 DNA 时。

据印度医学研究委员会 (ICMR) 称，到 2027 年，印度的癌症病例将增加 12%。

基因检测需求不断成长

基因检测需求的不断增长是聚合酶炼式反应市场的关键驱动因素。基因测试涉及分析个体的 DNA，以识别遗传变异、突变和基因表现模式。 PCR 透过扩增特定 DNA 序列以进行进一步分析，在此过程中发挥重要作用。此外，基因测试在那些对自己的血统感到好奇并想要探索自己的遗传遗产的人中越来越受欢迎。因此，这些进步正在扩大 PCR 在基因检测中的应用，并促进 PCR 市场的成长。

高成本

PCR 设备、试剂和消耗品的初始投资，加上对熟练人员的需求，增加了整体成本，特别是对于较小的诊断设施和实验室。 PCR 设备的复杂性和持续的品管要求进一步增加了营运成本。此外，PCR 检测的成本会对患者和医疗保健系统造成负担，影响尖端诊断服务的负担能力和公平分配。因此，高成本是市场拓展的主要障碍。

技术进步

即时 PCR 可以即时检测和定量 PCR 扩增，在扩增过程中提供即时结果。这种即时监测可以实现更快、更准确的分析，使其在临床诊断、基因检测和研究等领域发挥作用。此外，PCR 设备技术的进步促进了更容易使用的自动化系统的开发。整合热聚合酵素连锁反应热迴圈仪具有先进的温度控制演算法和直觉的软体介面，使包括研究人员、临床医生和技术人员在内的广大用户更容易使用 PCR。这些技术进步是加速市场需求的主要因素。

复杂性与专业知识

PCR技术涉及的各个步骤，包括引子设计、反应条件最佳化和资料分析，都需要一定程度的技术知识和训练。 PCR 方案需要仔细设计和选择专门特异性感兴趣的 DNA 区域的引子。设计具有适当熔解温度的引子、避免二级结构并最大限度地减少引子-二聚体相互作用是一项挑战。进行聚合酶链反应所需的复杂性和技术专业知识是聚合酶链反应市场的抑制因素。

COVID-19 的影响

COVID-19 大流行严重影响了聚合酶炼式反应市场的成长。临床诊断细分市场需求的不断增长对 PCR 市场产生了积极影响。医学专家建议出现 COVID-19 症状的人接受诊断测试，几乎所有这些测试都使用 RT-PCR，因为当局不建议进行病毒培养测试。许多製药和生物技术公司的研发部门都专注于寻找用于治疗 COVID-19 的新分子和先导化合物。

预计试剂细分市场在预测期内将是最大的

试剂部分估计占最大占有率。 PCR 试剂包括多种化学物质，包括 DNA 聚合酶、引子、核苷酸和缓衝液，每种物质在反应中都扮演着特定的角色。 DNA聚合酶，例如Taq聚合酶，催化互补DNA链的合成，引子提供DNA扩增的起点。核苷酸作为新合成 DNA 链的建构模组，缓衝液维持酵素活性的最佳 pH 条件。为了确保 PCR 反应的准确性和效率，对高品质和可靠试剂的需求至关重要。

预计诊断中心细分市场在预测期内复合年增长率最高

预计诊断中心部门在预测期内将出现良好的成长。 PCR技术广泛应用于诊断中心，用于检测各种疾病，包括感染疾病、遗传疾病和癌症。诊断中心利用 PCR 的高灵敏度和特异性来识别和量化特定的 DNA 或 RNA 序列，有助于早期、准确地诊断疾病。 PCR 的多功能性使诊断中心能够提供广泛的测试，有助于全面的患者照护。

占有率最大的地区

在估计期间，北美占据了最大的市场占有率。高频率的疾病、该地区重要参与企业的存在、有利的法规以及与医疗保健基础设施进步相关的众多政府倡议有助于该地区市场的成长。此外，患者对成功诊断的尖端产品的认识不断增强也推动了成长。

复合年增长率最高的地区：

由于感染疾病发病率上升、个人化医疗意识不断增强以及医疗保健系统的改善，预计亚太地区将在预测期内实现有益增长。亚洲国家的研究活动不断增加，特别是在基因组研究、肿瘤学和感染疾病研究领域。因此，PCR 作为一种准确、有效的 DNA 扩增方法已被广泛应用。此外，该地区多样化的人口和遗传变异需要强大的分子诊断来实现个体化治疗策略，这进一步推动了 PCR 市场的发展。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球聚合酶炼式反应市场：副产品

  • 介绍
  • 装置
    • 数位PCR系统
    • 标准PCR系统
    • 实时萤光定量PCR系统
  • 试剂
  • 消耗品
  • 其他产品

第六章全球聚合酶炼式反应市场：依应用分类

  • 介绍
  • 肿瘤学
  • 验血
  • 病原体检测
  • 研究
  • 法医学
  • 其他用途

第七章全球聚合酶炼式反应市场：依最终用户分类

  • 介绍
  • 药品
  • 医院
  • 临床研究所
  • 诊断中心
  • 学术界
  • 研究机构
  • 其他最终用户

第八章全球聚合酶炼式反应市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Danaher Corporation
  • Fluidigm Corporation
  • Agilent Technologies, Inc.
  • Stilla Technologies
  • Abbott
  • Cytiva
  • Microsynth AG
  • Qiagen
  • JN Medsys
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens
  • Johnson & Johnson Private Limited
  • Bruker
Product Code: SMRC24535

According to Stratistics MRC, the Global Polymerase Chain Reaction (PCR) Market is accounted for $8.9 billion in 2023 and is expected to reach $19.1 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Polymerase Chain Reaction (PCR) is a molecular method for producing millions of copies of a particular DNA strand through in-vitro amplification. PCR is highly sensitive and can detect minute quantities of DNA. This is particularly advantageous in applications where the target DNA is present in low concentrations, such as in the early stages of certain diseases or when analyzing trace amounts of DNA in forensic samples.

According to Indian Council of Medical Research (ICMR), there will be a 12 percent rise in cancer cases in India by the 2027.

Market Dynamics:

Driver:

Rising demand for genetic testing

The rising demand for genetic testing has been a significant driver in the polymerase chain reaction (PCR) market. Genetic testing involves the analysis of an individual's DNA to identify genetic variations, mutations, and gene expression patterns. PCR plays a crucial role in this process by amplifying specific DNA sequences for further analysis. Additionally, genetic testing has gained popularity among individuals who are curious about their ancestry and want to explore their genetic heritage. Therefore, these advancements have expanded the applications of PCR in genetic testing, contributing to the growth of the PCR market.

Restraint:

High cost

The initial investment in PCR instruments, reagents, and consumables, coupled with the need for skilled personnel, contributes to the overall expense, especially for smaller diagnostic facilities and laboratories. The sophisticated nature of PCR equipment and the continuous requirement for quality control further add to the operational costs. Additionally, the expense of PCR tests may burden patients and healthcare systems, impacting the affordability and equitable distribution of cutting-edge diagnostic services. Therefore, high costs are a significant barrier to market expansion.

Opportunity:

Technological advancements

Real-time PCR allows for the detection and quantification of PCR amplification in real-time, providing immediate results during the amplification process. This real-time monitoring enables faster and more precise analysis, making it valuable in fields such as clinical diagnostics, genetic testing, and research. Furthermore, advancements in PCR instrument technology have resulted in more user-friendly and automated systems. Integrated thermal cyclers with advanced temperature control algorithms and intuitive software interfaces have made PCR more accessible to a broader range of users, including researchers, clinicians, and technicians. These advancements in technology are a significant factor in accelerating market demand.

Threat:

Complexity and technical expertise

A certain level of technical knowledge and training is required for the various steps involved in PCR techniques, which include primer design, reaction condition optimization, and data analysis. PCR protocols require careful design and selection of primers that specifically target the desired DNA regions. Designing primers with appropriate melting temperatures, avoiding secondary structures, and minimizing primer-dimer interactions can be challenging. The complexity and technical expertise required to perform polymerase chain reaction (PCR) act as restraints in the polymerase chain reaction (PCR) market.

COVID-19 Impact

The COVID-19 pandemic significantly impacted the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market segment had a favourable effect on the PCR market. Healthcare professionals advised the population exhibiting COVID-19 symptoms to have a diagnostic test performed, and nearly all of these tests use RT-PCR since viral culture tests have not been recommended by the authorities. Most pharmaceutical and biotechnological companies were focusing on the research and development departments to identify new molecules or leads for the treatment of COVID-19.

The reagents segment is expected to be the largest during the forecast period

The reagents segment is estimated to hold the largest share. PCR reagents encompass a range of chemicals, including DNA polymerases, primers, nucleotides, and buffers, each playing a specific role in the reaction. DNA polymerases, such as Taq polymerase, catalyze the synthesis of complementary DNA strands, while primers provide the starting points for DNA amplification. Nucleotides serve as building blocks for the newly synthesized DNA strands, and buffers maintain the optimal pH conditions for enzymatic activity. The demand for high-quality and reliable reagents is paramount for the accuracy and efficiency of PCR reactions.

The diagnostic center segment is expected to have the highest CAGR during the forecast period

The diagnostic center segment is anticipated to have lucrative growth during the forecast period. PCR technology is extensively utilized in diagnostic centers for the detection of various diseases, including infectious agents, genetic disorders, and cancer. Diagnostic centers leverage PCR's high sensitivity and specificity to identify and quantify specific DNA or RNA sequences, aiding in the early and precise diagnosis of diseases. The versatility of PCR enables diagnostic centers to offer a wide range of tests, contributing to comprehensive patient care.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The high frequency of diseases, the presence of important players in the region, the existence of favourable regulations, and a number of government initiatives pertaining to advancements in healthcare infrastructure all contribute to the growth of the regional market. An additional factor fueling the growth is growing patient awareness of the availability of contemporary products for successful diagnosis.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the rising incidence of infectious diseases, the growing recognition of personalized medicine, and the improvements made to the healthcare system. Asian countries are seeing an increase in research endeavours, specifically in the fields of genomics, oncology, and infectious disease investigations. This has led to the widespread use of PCR as a precise and efficient method of amplifying DNA. Moreover, the region's diverse population and genetic variations necessitate robust molecular diagnostics for personalized treatment strategies, further fueling the PCR market.

Key players in the market:

Some of the key players in the Polymerase Chain Reaction (PCR) Market include Danaher Corporation, Fluidigm Corporation, Agilent Technologies, Inc., Stilla Technologies, Abbott, Cytiva, Microsynth AG, Qiagen, JN Medsys, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Siemens, Johnson & Johnson Private Limited and Bruker.

Key Developments:

In August 2022, Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals. Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health.

In June 2021, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products.

Products Covered:

  • Instruments
  • Reagents
  • Consumables
  • Other Products

Applications Covered:

  • Oncology
  • Blood Testing
  • Pathogen Detection
  • Research
  • Forensic
  • Other Applications

End Users Covered:

  • Pharmaceutical
  • Hospital
  • Clinical Research Organizations
  • Diagnostic Center
  • Academia
  • Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Polymerase Chain Reaction (PCR) Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Digital PCR Systems
    • 5.2.2 Standard PCR Systems
    • 5.2.3 Real-Time PCR Systems
  • 5.3 Reagents
  • 5.4 Consumables
  • 5.5 Other Products

6 Global Polymerase Chain Reaction (PCR) Market, By Application

  • 6.1 Introduction
  • 6.2 Oncology
  • 6.3 Blood Testing
  • 6.4 Pathogen Detection
  • 6.5 Research
  • 6.6 Forensic
  • 6.7 Other Applications

7 Global Polymerase Chain Reaction (PCR) Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical
  • 7.3 Hospital
  • 7.4 Clinical Research Organizations
  • 7.5 Diagnostic Center
  • 7.6 Academia
  • 7.7 Laboratories
  • 7.8 Other End Users

8 Global Polymerase Chain Reaction (PCR) Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Danaher Corporation
  • 10.2 Fluidigm Corporation
  • 10.3 Agilent Technologies, Inc.
  • 10.4 Stilla Technologies
  • 10.5 Abbott
  • 10.6 Cytiva
  • 10.7 Microsynth AG
  • 10.8 Qiagen
  • 10.9 JN Medsys
  • 10.10 Bio-Rad Laboratories, Inc.
  • 10.11 Thermo Fisher Scientific, Inc.
  • 10.12 F. Hoffmann-La Roche Ltd
  • 10.13 Siemens
  • 10.14 Johnson & Johnson Private Limited
  • 10.15 Bruker

List of Tables

  • Table 1 Global Polymerase Chain Reaction (PCR) Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 5 Global Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 6 Global Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 7 Global Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 8 Global Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 9 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 12 Global Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 13 Global Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 14 Global Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 15 Global Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 16 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Global Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 19 Global Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 20 Global Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 21 Global Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 22 Global Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 23 Global Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 24 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 28 North America Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 29 North America Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 30 North America Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 31 North America Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 32 North America Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 33 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 34 North America Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 North America Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 36 North America Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 37 North America Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 38 North America Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 39 North America Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 40 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 North America Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 43 North America Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 44 North America Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 45 North America Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 46 North America Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 47 North America Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 48 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 52 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 53 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 54 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 55 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 56 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 57 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 58 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 59 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 60 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 61 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 62 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 63 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 64 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 65 Europe Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 66 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 67 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 68 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 69 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 70 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 71 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 72 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 76 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 77 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 78 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 79 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 80 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 81 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 82 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 83 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 84 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 85 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 86 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 87 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 88 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 89 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 90 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 91 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 92 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 93 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 94 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 95 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 96 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 100 South America Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 101 South America Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 102 South America Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 103 South America Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 104 South America Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 105 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 106 South America Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 South America Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 108 South America Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 109 South America Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 110 South America Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 111 South America Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 112 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 113 South America Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 114 South America Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 115 South America Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 116 South America Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 117 South America Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 118 South America Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 119 South America Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 120 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 124 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 125 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 126 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 127 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 128 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 129 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 130 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 131 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 132 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 133 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 134 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 135 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 136 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 137 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 138 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 139 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 140 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 141 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 142 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 143 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 144 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)